| Product Code: ETC7906377 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Bradykinin Mediated Angioedema Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Bradykinin Mediated Angioedema Market - Industry Life Cycle |
3.4 Latvia Bradykinin Mediated Angioedema Market - Porter's Five Forces |
3.5 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Bradykinin Mediated Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of bradykinin-mediated angioedema in Latvia |
4.2.2 Growing research and development activities focusing on new treatments for bradykinin-mediated angioedema |
4.2.3 Favorable government policies and regulations supporting the treatment and management of angioedema |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for the diagnosis and treatment of bradykinin-mediated angioedema |
4.3.2 High treatment costs associated with bradykinin-mediated angioedema therapies |
4.3.3 Lack of skilled healthcare professionals with expertise in managing bradykinin-mediated angioedema cases |
5 Latvia Bradykinin Mediated Angioedema Market Trends |
6 Latvia Bradykinin Mediated Angioedema Market, By Types |
6.1 Latvia Bradykinin Mediated Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By C1-INH Concentrates, 2021- 2031F |
6.1.4 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Bradykinin B2-Receptor Antagonist, 2021- 2031F |
6.1.5 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Icatibant, 2021- 2031F |
6.1.6 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.7 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Ecallantide, 2021- 2031F |
6.1.8 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Bradykinin Mediated Angioedema Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.3 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Bradykinin Mediated Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Latvia Bradykinin Mediated Angioedema Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Latvia Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Bradykinin Mediated Angioedema Market Import-Export Trade Statistics |
7.1 Latvia Bradykinin Mediated Angioedema Market Export to Major Countries |
7.2 Latvia Bradykinin Mediated Angioedema Market Imports from Major Countries |
8 Latvia Bradykinin Mediated Angioedema Market Key Performance Indicators |
8.1 Number of clinical trials conducted for new bradykinin-mediated angioedema treatments |
8.2 Percentage increase in the number of healthcare professionals specializing in angioedema management |
8.3 Patient satisfaction scores with access to angioedema treatment services |
9 Latvia Bradykinin Mediated Angioedema Market - Opportunity Assessment |
9.1 Latvia Bradykinin Mediated Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Bradykinin Mediated Angioedema Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Latvia Bradykinin Mediated Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Latvia Bradykinin Mediated Angioedema Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Bradykinin Mediated Angioedema Market - Competitive Landscape |
10.1 Latvia Bradykinin Mediated Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Latvia Bradykinin Mediated Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here